Why the study?
Transesophageal overdrive pacing is an accepted method for the diagnosis and treatment of supraventricular tachycardias, but it is not used frequently in clinical practice.
Transesophageal overdrive atrial pacing is a simple, safe, and low-cost bedside procedure for converting atrial tachycardia, particularly useful in patients with complex comorbidities like β-Thalassemia Major where antiarrhythmic drugs may be problematic.
Answers are grounded in this paper and cite their sources.
May support use in β-thalassemia; leaves open need for controlled trials before wider adoption.
INTRODUCTION: Transesophageal overdrive pacing is an accepted method for the diagnosis and treatment of supraventricular tachycardias, although is not used frequently in clinical practice. CASE REPORT: A 47 years old woman is reported with a medical history of β -Thalassemia Major admitted to our hospital with atrial tachycardia of recent onset and successfully converted using a transesophageal overdrive atrial pacing. CONCLUSION: Transesophageal overdrive atrial pacing is a low cost, simple and safe procedure that can be performed at the bedside, especially in patients, as those with β -Thalassemia Major, whose health status makes difficult the usage of medicines that could possibly aggravate their general health status.
No takes yet. Share an insight, caveat, or question.
Koutsampasopoulos et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: